Literature DB >> 16302169

Peptidyl-prolyl isomerase inhibitors.

Xiaodong J Wang1, Felicia A Etzkorn.   

Abstract

Designed peptidyl-prolyl isomerase (PPIase) inhibitors of Pin1, cyclophilin (CyP), and FK506 binding protein (FKBP) are reviewed. Emphasis is placed on the design, structure, and biological activity of the inhibitors. While CyP and FKBP inhibitors have been explored fairly thoroughly, inhibitors of the relatively new Pin1 cell cycle regulator are in their infancy. Ligands designed for Pin1 and CyP have primarily been ground state analogues: alkenes and bicyclic compounds. For FKBP, more of the focus has been on analogues of bonds at the reactive center, the prolyl amide, because of the idea that the alpha-ketoamide of FK506 is an analogue of the twisted amide in the transition state. Copyright 2005 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16302169     DOI: 10.1002/bip.20240

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  21 in total

Review 1.  Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors:  Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 2.  An evaluation of peptide-bond isosteres.

Authors:  Amit Choudhary; Ronald T Raines
Journal:  Chembiochem       Date:  2011-07-12       Impact factor: 3.164

Review 3.  Cyclophilin D in mitochondrial pathophysiology.

Authors:  Valentina Giorgio; Maria Eugenia Soriano; Emy Basso; Elena Bisetto; Giovanna Lippe; Michael A Forte; Paolo Bernardi
Journal:  Biochim Biophys Acta       Date:  2009-12-21

Review 4.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

5.  Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation.

Authors:  Angélique Deleersnijder; Anne-Sophie Van Rompuy; Linda Desender; Hans Pottel; Luc Buée; Zeger Debyser; Veerle Baekelandt; Melanie Gerard
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

6.  Synthesis of the C21-C34 fragment of antascomicin B.

Authors:  John M Hutchison; Andrew S Gibson; David T Williams; Matthias C McIntosh
Journal:  Tetrahedron Lett       Date:  2011-10-30       Impact factor: 2.415

7.  Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain.

Authors:  Robert A Hom; Pei-Yun Chang; Siddhartha Roy; Catherine A Musselman; Karen C Glass; Anna I Selezneva; Or Gozani; Rustem F Ismagilov; Michael L Cleary; Tatiana G Kutateladze
Journal:  J Mol Biol       Date:  2010-05-08       Impact factor: 5.469

8.  Small family with key contacts: par14 and par17 parvulin proteins, relatives of pin1, now emerge in biomedical research.

Authors:  Jonathan W Mueller; Peter Bayer
Journal:  Perspect Medicin Chem       Date:  2008-03-07

9.  Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1.

Authors:  Koichi Watashi; Mohammad Khan; Venkat R K Yedavalli; Man Lung Yeung; Klaus Strebel; Kuan-Teh Jeang
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

10.  Isoform-specific inhibition of cyclophilins.

Authors:  Sebastian Daum; Michael Schumann; Sebastian Mathea; Tobias Aumüller; Molly A Balsley; Stephanie L Constant; Boris Féaux de Lacroix; Fabian Kruska; Manfred Braun; Cordelia Schiene-Fischer
Journal:  Biochemistry       Date:  2009-07-07       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.